npj Microgravity Article: Alterations in adaptive immunity persist during long-duration spaceflight

This article by Brian Crucian and Duane Pierson (NASA Johnson Space Center, Houston, TX, USA), Raymond P Stowe (Microgen Laboratories, La Marque, TX, USA), Satish Mehta (Enterprise Advisory Services, Inc., Houston, TX, USA), Heather Quiriarte (JES Tech, Houston, TX, USA) and Clarence Sams (Space and Clinical Operations Division, Houston, TX, USA) was published online by npj Microgravity on September 3, 2015.

Go to the profile of Andrea Macaluso
Dec 16, 2015
0
0

Abstract

Background

It is currently unknown whether immune system alterations persist during long-duration spaceflight. In this study various adaptive immune parameters were assessed in astronauts at three intervals during 6-month spaceflight on board the International Space Station (ISS).

Aims

To assess phenotypic and functional immune system alterations in astronauts participating in 6-month orbital spaceflight.

Methods

Blood was collected before, during, and after flight from 23 astronauts participating in 6-month ISS expeditions. In-flight samples were returned to Earth within 48 h of collection for immediate analysis. Assays included peripheral leukocyte distribution, T-cell function, virus-specific immunity, and mitogen-stimulated cytokine production profiles.

Results

Redistribution of leukocyte subsets occurred during flight, including an elevated white blood cell (WBC) count and alterations in CD8+ T-cell maturation. A reduction in general T-cell function (both CD4+ and CD8+) persisted for the duration of the 6-month spaceflights, with differential responses between mitogens suggesting an activation threshold shift. The percentage of CD4+ T cells capable of producing IL-2 was depressed after landing. Significant reductions in mitogen-stimulated production of IFNγ, IL-10, IL-5, TNFα, and IL-6 persisted during spaceflight. Following lipopolysaccharide (LPS) stimulation, production of IL-10 was reduced, whereas IL-8 production was increased during flight.

Conclusions

The data indicated that immune alterations persist during long-duration spaceflight. This phenomenon, in the absence of appropriate countermeasures, has the potential to increase specific clinical risks for crewmembers during exploration-class deep space missions.

Read this article in full...

Go to the profile of Andrea Macaluso

Andrea Macaluso

Publisher, Nature Partner Journals, Springer Nature

Publisher, Nature Partner Journals, responsible for the US & Latin America, working with world renowned partners aimed at advancing science.

No comments yet.